Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus
- PMID: 16785458
- PMCID: PMC1475921
- DOI: 10.1503/cmaj.051446
Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus
Abstract
Patent ductus arteriosus is one of the most common congenital abnormalities found in premature infants. Ibuprofen, a nonsteroidal drug that is commonly used as an antipyretic, analgesic and anti-inflammatory agent, is also used to induce closure of symptomatic patent ductus arteriosus in preterm infants. Recently, we gave L-lysine ibuprofen to a preterm infant with respiratory distress to induce closure of a patent ductus arteriosus, and the infant experienced pulmonary hypertension. Only 3 cases of pulmonary hypertension following early administration of an ibuprofen solution buffered with tromethamine have previously been reported. However, this severe side effect has never been observed in multicentre, randomized, double-blind controlled trials, nor in recent reviews or meta-analyses of L-lysine ibuprofen use.
Figures
Comment in
-
Re-examining our approach to the approval and use of new drugs.CMAJ. 2006 Jun 20;174(13):1855. doi: 10.1503/cmaj.060581. CMAJ. 2006. PMID: 16785460 Free PMC article. No abstract available.
References
-
- Wyllie J. Treatment of patent ductus arteriosus. Semin Neonatol 2003;8:425-32. - PubMed
-
- Thomas RL, Parker GC, Van Overmeire B, et al. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 2005;164:135-40. - PubMed
-
- Shah SS, Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants [Cochrane Review]. In: The Cochrane Library; Issue 2, 2005. Oxford: Update Software. - PubMed
-
- Gournay V, Roze JC, Kuster A, et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet 2004;364:1939-44. - PubMed
-
- Van Overmeire B, Allegaert K, Casaer A, et al.; Multicentre Ibuprofen Prophylaxis Study (MIPS) Investigators. Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2004;364:1945-9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical